Jant Pharmacal Corporation is Awarded Contract From Vizient

Jant Pharmacal Corporation is Awarded Contract From Vizient

Press Release (ePRNews.com) - ENCINO, Calif. - Jan 07, 2020 - Jant Pharmacal Corporation announces it has been awarded a contract with Vizient, Inc. for its complete line of rapid test kits. The contract takes effect Feb. 1, 2020, and offers enhanced savings on the test kits for Vizient members.

The contract covers Jant’s full line of test kits, which is comprised of tests for cancer screening, drugs of abuse, infectious disease, pregnancy, and urinalysis.

Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and nonacute health care providers and represents more than $100 billion in annual purchasing volume.

About Jant Pharmacal Corporation

Jant Pharmacal is a major supplier of medical testing devices for use in physician’s offices, clinics, hospitals and laboratory practice settings. Point of care products are marketed under registered trademarks Accutest® and Accustrip®. Established in 1986, Jant Pharmacal’s point of care diagnostic products are FDA cleared, CLIA-waived and are backed by over 30 years of experience and industry leadership.

In addition, Jant Pharmacal offers a comprehensive line of laboratory equipment, including clinical chemistry, hematology, immunoassay, molecular and urinalysis systems and reagents, as well as consultative services, to enhance laboratory efficiency and profitability.

More information on the Company’s products and services can be found on their website, www.JantDx.com. Their customer service team can be reached by email at info@JantDX.com or by phone at (800) 676-5565.

Media Contact:
Vanessa Perez
Phone: 800.676.5565
Email: info@jantdx.com

Source : Jant Pharmacal Corporation

You may also like this  


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.